Palatin Technologies Inc (PTN) - Total Liabilities
Based on the latest financial reports, Palatin Technologies Inc (PTN) has total liabilities worth $10.12 Million USD as of March 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Palatin Technologies Inc annual equity growth to track the company's year-over-year net asset growth rate.
Palatin Technologies Inc - Total Liabilities Trend (1996–2024)
This chart illustrates how Palatin Technologies Inc's total liabilities have evolved over time, based on quarterly financial data. See Palatin Technologies Inc (PTN) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Palatin Technologies Inc Competitors by Total Liabilities
The table below lists competitors of Palatin Technologies Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Baronsmead Second Venture Trust Plc
LSE:BMD
|
UK | GBX1.47 Million |
|
Creative Medical Technology Holdings Inc
NASDAQ:CELZ
|
USA | $307.65K |
|
BLACK PEARL ZY-10
F:7ZX
|
Germany | €4.76 Million |
|
Netcall plc
LSE:NET
|
UK | GBX47.25 Million |
|
Quest PharmaTech Inc
V:QPT
|
Canada | CA$1.25 Million |
|
Alpha Star Acquisition Corp
NASDAQ:ALSA
|
USA | $2.97 Million |
|
GRI Bio Inc.
NASDAQ:GRI
|
USA | $794.00K |
|
Ocean Sun As
OL:OSUN
|
Norway | Nkr7.65 Million |
Liability Composition Analysis (1996–2024)
This chart breaks down Palatin Technologies Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see PTN market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.32 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.58 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 2.71 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Palatin Technologies Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Palatin Technologies Inc (1996–2024)
The table below shows the annual total liabilities of Palatin Technologies Inc from 1996 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-06-30 | $10.85 Million | -39.04% |
| 2023-06-30 | $17.81 Million | -10.09% |
| 2022-06-30 | $19.80 Million | +12.23% |
| 2021-06-30 | $17.65 Million | +261.52% |
| 2020-06-30 | $4.88 Million | +16.60% |
| 2019-06-30 | $4.19 Million | -65.27% |
| 2018-06-30 | $12.05 Million | -80.56% |
| 2017-06-30 | $62.00 Million | +116.49% |
| 2016-06-30 | $28.64 Million | +65.82% |
| 2015-06-30 | $17.27 Million | +523.41% |
| 2014-06-30 | $2.77 Million | +32.18% |
| 2013-06-30 | $2.10 Million | -40.96% |
| 2012-06-30 | $3.55 Million | +19.07% |
| 2011-06-30 | $2.98 Million | -2.92% |
| 2010-06-30 | $3.07 Million | -68.94% |
| 2009-06-30 | $9.89 Million | -21.37% |
| 2008-06-30 | $12.57 Million | -48.15% |
| 2007-06-30 | $24.25 Million | +11.50% |
| 2006-06-30 | $21.75 Million | -16.17% |
| 2005-06-30 | $25.94 Million | +419.61% |
| 2004-06-30 | $4.99 Million | +22.83% |
| 2003-06-30 | $4.06 Million | +10.71% |
| 2002-06-30 | $3.67 Million | +57.67% |
| 2001-06-30 | $2.33 Million | +17.59% |
| 2000-06-30 | $1.98 Million | -54.99% |
| 1999-06-30 | $4.40 Million | +41.94% |
| 1998-06-30 | $3.10 Million | -27.91% |
| 1997-06-30 | $4.30 Million | +2.31% |
| 1996-06-30 | $4.20 Million | -- |
About Palatin Technologies Inc
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that is… Read more